Role of hepatic autoregulation in defense against hypoglycemia in humans.
- 1 May 1985
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 75 (5) , 1623-1631
- https://doi.org/10.1172/jci111869
Abstract
To assess the role of hepatic autoregulation in defense against hypoglycemia, we compared the effects of complete blockade of glucose counterregulation with those of blockade of only neurohumoral counterregulation during moderate (approximately 50 mg/dl) and severe (approximately 30 mg/dl) hypoglycemia induced by physiologic hyperinsulinemia during subcutaneous infusion of insulin in normal volunteers. Compared with observations in control experiments, neurohumoral counterregulatory blockade (somatostatin, propranolol, phentolamine, and metyrapone), during which identical moderate hypoglycemia was achieved using the glucose clamp technique, resulted in suppressed glucose production (0.62 +/- 0.08 vs. 1.56 +/- 0.07 mg/kg per min at 12 h, P less than 0.01) and augmented glucose utilization (2.17 +/- 0.18 vs. 1.57 +/- 0.07 mg/kg per min at 12 h, P less than 0.01). Complete blockade of counterregulation (neurohumoral blockade plus prevention of hypoglycemia) did not further enhance the suppressive effects of insulin on glucose production. However, when severe hypoglycemia was induced during neurohumoral counterregulatory blockade, glucose production was nearly two times greater (1.05 +/- 0.05 mg/kg per min at 9 h) than that observed during complete counterregulatory blockade (0.58 +/- 0.08 mg/kg per min at 9 h, P less than 0.01) and that observed during mere neurohumoral blockade with moderate hypoglycemia (0.59 +/- 0.06 mg/kg per min at 9 h, P less than 0.01). These results demonstrate that glucose counterregulation involves both neurohumoral and hepatic autoregulatory components: neurohumoral factors, which require only moderate hypoglycemia for their activation, augment glucose production and reduce glucose utilization; hepatic autoregulation requires severe hypoglycemia for its activation and may thus serve as an emergency system to protect the brain when other counterregulatory factors fail to prevent threatening hypoglycemia.This publication has 53 references indexed in Scilit:
- Tissue effects of glucocorticoidsThe American Journal of Medicine, 1972
- Glucose-Lactate Inter-Relations in ManNew England Journal of Medicine, 1972
- A sensitive and specific fluorimetric method for the determination of noradrenalin and adrenalin in human plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1970
- Amino acid balance across tissues of the forearm in postabsorptive man. Effects of insulin at two dose levelsJournal of Clinical Investigation, 1969
- Intrinsic regulation of glucose output by rat liverAmerican Journal of Physiology-Legacy Content, 1969
- Glucose regulation of hepatic gluconeogenesisAmerican Journal of Physiology-Legacy Content, 1968
- Autoregulation of Glucose Metabolism in the Isolated Perfused Rat Liver.Experimental Biology and Medicine, 1967
- Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver.Proceedings of the National Academy of Sciences, 1966
- A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasmaJournal of Clinical Pathology, 1962
- Microdetermination of Long-chain Fatty Acids in Plasma and TissuesJournal of Biological Chemistry, 1960